Pateclizumab Biosimilar - Research Grade

Human

LTAï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P01374

Blue ice

Lymphotoxin alpha (LTA/TNF-β) is a TNF-superfamily cytokine involved in lymphoid organogenesis and inflammation. This human IgG1 kappa antibody is an unconjugated, non-therapeutic analog of pateclizumab, expressed in CHO cells against human LTA. For research use only, it is purified to low endotoxin for in vivo compatibility and manufactured in scalable milligram (mg) to gram (g) quantities for high-throughput laboratories. It serves as a consistent reagent for cytokine-neutralization assays, signaling studies, functional characterization, and preclinical models of autoimmune inflammation. Consistent lot-to-lot performance makes it dependable for repeated, large-scale experimentation.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks